Rapport Therapeutics, Inc.'s market cap is currently $1.23B. The company's EPS TTM is $-0.75; its P/E ratio is ―; Rapport Therapeutics, Inc. is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.78. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Currency in USD
Rapport Therapeutics, Inc. Earnings and Revenue History
